THAR

Tharimmune, Inc. THAR

THAR
Tharimmune, Inc. BLRX
BioLineRx Ltd. GOVX
GeoVax Labs, Inc. ANL
Adlai Nortye Ltd. LNAI
Lunai Bioworks Inc. ICU
SeaStar Medical Holding Corporation ADAP
Adaptimmune Therapeutics plc AIMD
Ainos, Inc. APLM
Apollomics, Inc. ADTX
Aditxt, Inc.

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode THAR BLRX GOVX ANL LNAI ICU ADAP AIMD APLM ADTX
6M 73.13 % -28.30 % -83.14 % 3.40 % -53.95 % -30.55 % -80.83 % -16.60 % 193.42 % -99.22 %
YTD 13.17 % -70.25 % -93.58 % -37.70 % -53.95 % -87.45 % -92.22 % -15.60 % 54.86 % -99.98 %
1Y 12.08 % -65.88 % -92.80 % -31.53 % -53.95 % -87.70 % -91.75 % -10.21 % 76.24 % -99.98 %
3Y -98.37 % -86.90 % -98.20 % -89.87 % -53.95 % -99.77 % -96.58 % -86.60 % -98.39 % -100.00 %
5Y -99.82 % -97.12 % -99.67 % -89.87 % -53.95 % -99.90 % -99.02 % -96.32 % -98.31 % -100.00 %
10Y -99.82 % -99.62 % -99.64 % -89.87 % -53.95 % -99.90 % -99.51 % -96.32 % -98.31 % -100.00 %
From the beginning -99.82 % -99.91 % -99.64 % -89.87 % -53.95 % -99.90 % -99.70 % -96.32 % -98.31 % -100.00 %

Dividend